Bill Sponsor
Senate Simple Resolution 648
115th Congress(2017-2018)
A resolution designating September 2018 as "Pulmonary Fibrosis Awareness Month".
Active
Active
Passed Senate on Sep 25, 2018
Overview
Text
Introduced
Sep 25, 2018
Latest Action
Sep 25, 2018
Origin Chamber
Senate
Type
Simple Resolution
Simple Resolution
A form of legislative measure introduced and potentially acted upon by only one congressional chamber and used for the regulation of business only within the chamber of origin. Depending on the chamber of origin, they begin with a designation of either H.Res. or S.Res. Joint resolutions and concurrent resolutions are other types of resolutions.
Bill Number
648
Congress
115
Policy Area
Health
Health
Primary focus of measure is science or practice of the diagnosis, treatment, and prevention of disease; health services administration and funding, including such programs as Medicare and Medicaid; health personnel and medical education; drug use and safety; health care coverage and insurance; health facilities. Measures concerning controlled substances and drug trafficking may fall under Crime and Law Enforcement policy area.
Sponsorship by Party
Democrat
Delaware
Democrat
Connecticut
Democrat
Massachusetts
Democrat
Minnesota
Democrat
Minnesota
Senate Votes (1)
checkPassed on September 25, 2018
Status
Passed
Type
Voice Vote
Voice Vote
A vote in which the presiding officer states the question, then asks those in favor and against to say "Yea" or "Nay," respectively, and announces the result according to his or her judgment. The names or numbers of senators voting on each side are not recorded.
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Voice Vote.(consideration: CR S6311; text: CR S6308)
Summary

Designates September 2018 as Pulmonary Fibrosis Awareness Month. (Pulmonary fibrosis is scarring of the lungs that causes breathing problems.)

Expresses continued support for more robust and accelerated research to develop more effective treatments for pulmonary fibrosis and to ultimately find a cure for the disease.

Recognizes the ongoing courage and contributions of individuals with pulmonary fibrosis who participate in clinical trials.

Commends the dedication of those working to improve the quality of life of individuals with pulmonary fibrosis and the families of those individuals.
Text (1)
September 25, 2018
Actions (3)
09/25/2018
Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Voice Vote. (consideration: CR S6311; text: CR S6308)
09/25/2018
Passed/agreed to in Senate: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Voice Vote.(consideration: CR S6311; text: CR S6308)
09/25/2018
Introduced in Senate
Public Record
Record Updated
Dec 16, 2021 3:45:57 PM